期刊文献+

艾司西酞普兰联合家庭心理治疗对脑卒中患者生存质量的影响 被引量:7

Effect of Combination of Escitalopram and Family Psychotherapy on Life Quality of Stroke Patients
暂未订购
导出
摘要 目的:探讨单独使用艾司西酞普兰及艾司西酞普兰联合家庭心理治疗对脑卒中患者生存质量的影响及差异。方法:将128例入院的脑卒中患者随机分成艾司西酞普兰单独干预组(64例)和艾司西酞普兰联合家庭心理治疗干预组(64例),观察8周。采用《世界卫生组织生存质量测定量表简表》对干预前后所有患者的生存质量进行评价,并对生存质量的各个领域进行分析评价。结果:单用艾司西酞普兰及采用艾司西酞普兰联合家庭心理治疗的联合干预均能显著提高脑卒中患者的生存质量的各个领域的评分,联合干预效果更明显,但经过干预后患者生存质量仍然比正常人低。结论:艾司西酞普兰联合家庭心理治疗能显著改善脑卒中患者生存质量,更多干预的参加能进一步改善患者的生存质量。 Objective:To investigate the difference of the life quality of stroke patients between Escitaiopram alone and the combination of Escitaiopram and family psychotherapy.Methods:128 cases who receive therapy voluntarily were divided into two groups randomly,treated with Escitaiopram and Escitaiopram and family psychotherapy for 8 weeks.The WHO Quality of Life Scale(WHOQOL-BREF) was used to assess the Quality of Life before and after intervened therapy and the difference between the two groups in four domains in WHOQOL-BREF were analyzed with SPSS.Results:The only Escitaiopram and the combination of Escitaiopram and family psychotherapy can improve the scores of the four domains in Quality of Life distinctly and the group of combined therapy was more effective,but the scores of the four domains were also under the level of normal people.Conclusions:The combination of Escitaiopram and family psychotherapy can improve the life quality of stroke patients obviously.The intervention may be a good way to improve the life quality of stroke patients.
作者 向明清 杨涛
出处 《长江大学学报(自科版)(下旬)》 CAS 2010年第4期10-12,共3页 Journal of Yangtze University
关键词 艾司西酞普兰 脑卒中 家庭心理治疗 生存质量 Escitalopram Stroke attack Family psychotherapy Quality of life
  • 相关文献

参考文献10

二级参考文献13

共引文献33968

同被引文献63

  • 1张哲林,赵世刚.养血清脑颗粒联合帕罗西丁治疗卒中后抑郁的疗效观察[J].内蒙古医科大学学报,2012,34(S3):298-300. 被引量:6
  • 2谢瑞满,刘剑英.脑卒中后抑郁的治疗进展[J].中国处方药,2005,4(1):58-61. 被引量:13
  • 3张振馨.帕金森病的诊断[J].中华神经科杂志,2006,39(6):408-409. 被引量:619
  • 4司天梅,舒良.关于新抗抑郁药艾司西酞普兰[J].临床精神医学杂志,2007,17(1):68-69. 被引量:126
  • 5黄玉莹,李少清,李郭飞,赵秀红.卒中后抑郁、焦虑的干预和预后临床分析[J].中国实用神经疾病杂志,2007,10(3):25-26. 被引量:11
  • 6陈思宇,王鸿健.艾司西酞普兰治疗躯体形式障碍的临床疗效观察[J].实用心脑肺血管病杂志.2013,210):112-113.
  • 7陈清棠.全国第四届脑血管病学术会议.脑卒中患者临床神经功能缺损程度评分标准(1995)脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996(06):381-386.
  • 8Safa M, Sadr S, Talischi F, et al. Study of effects of selective serotonin reuptake inhibitors on stages of sexual lhnction in Iranian patients with major depressive disorder[J]. Ther Adv P.sychopharmacol, 2013, 3(6): 306-313.
  • 9Pae C U. Pramipexole augmentation in treatment-resistant major depressive disorder[J]. Expert Rev Neurother, 2014, 14(1): 5-8.
  • 10Cusin C, lovieno N, Iosifescu D V, et al. A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment- resistant major depressive disorder[J]. J Clin Psychiatry, 2013, 74(7): e636-641.

引证文献7

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部